Tong Victor Edward Jr 4
4 · CG Oncology, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
CG Oncology (CGON) Director Victor Tong Receives 9,354-Share Option Award
What Happened
- Victor Edward Tong Jr., a director of CG Oncology, was granted a derivative award covering 9,354 shares on 2026-06-04. The transaction is reported as an Award/Grant (code A) at $0.00 per share (no cash paid at grant). This was a grant of stock options (derivative securities), not a purchase or sale.
Key Details
- Transaction date: 2026-06-04; Filing date: 2026-06-05 (timely).
- Reported price: $0.00 per share (grant reported with no cash exchanged at time of grant).
- Number of shares/options granted: 9,354 (derivative securities).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Vesting: Footnote states 1/12th of the total option vests monthly beginning June 4, 2026; if the issuer’s next annual meeting occurs before the first anniversary, any remaining unvested portion will vest at that meeting, subject to continuous service.
- Transaction code: A = Award/Grant of derivative securities.
Context
- This was a time-based equity grant subject to vesting — the options were not exercised or sold. Such grants compensate and retain insiders and do not by themselves indicate immediate buying or selling pressure. For retail investors, vested or exercised purchases/sales convey clearer near-term insider conviction than unvested option grants.
Insider Transaction Report
Form 4
Tong Victor Edward Jr
Director
Transactions
- Award
Director Stock Option (right to buy)
[F1]2026-06-04+9,354→ 9,354 totalExercise: $56.09Exp: 2036-06-03→ Common Stock (9,354 underlying)
Footnotes (1)
- [F1]1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Victor Edward Tong, Jr.|2026-06-05